Edition:
United Kingdom

Arsanis Inc (ASNS.OQ)

ASNS.OQ on NASDAQ Stock Exchange Global Market

1.48USD
18 Oct 2018
Change (% chg)

$-0.06 (-3.90%)
Prev Close
$1.54
Open
$1.52
Day's High
$1.55
Day's Low
$1.48
Volume
21,568
Avg. Vol
39,210
52-wk High
$27.83
52-wk Low
$1.47

Chart for

About

Arsanis, Inc. is a biopharmaceutical company. The Company is focused on the discovering and developing monoclonal antibodies (mAbs) for the targeted immunotherapy of serious infections. The Company's mAbs focus on specific pathogens and pathogenic processes. Its product pipeline includes ASN100, ASN200, ASN300, ASN400 and... (more)

Overall

No Ratios Available.

Financials

  ASNS.OQ Industry Sector
P/E (TTM): -- 85.68 33.65
EPS (TTM): -- -- --
ROI: -- 0.45 14.28
ROE: -- 1.37 16.00

BRIEF-Arsanis Posts Qtrly Loss Per Share $0.74

* ASN100 PHASE 2 TRIAL INTERIM ANALYSIS RESULTS EXPECTED IN LATE JUNE

10 May 2018

Earnings vs. Estimates